Depression is one of the most common comorbidities of many chronic medical diseases
including cancer and cardiovascular, metabolic, inflammatory and neurological disorders …

Depression and fatigue are conditions responsible for heavy global societal burden,
especially in patients already suffering from chronic diseases. These symptoms have been …

Depression is twice as common in people with type 1 or type 2 diabetes as in the general
population, and is associated with poor outcomes. Evidence is growing that depression and …

To conduct a systematic review and meta‐analysis of longitudinal studies assessing the bi‐
directional association between depression and diabetes macrovascular and microvascular …

Inflammatory illness is associated with depression. Preclinical work has shown that
chemokines are linked with peripheral–central crosstalk and may be important in mediating …

Objective To provide an estimate of the effect of interventions on comorbid depressive
disorder (MDD) or subthreshold depression in type 1 and type 2 diabetes. Methods …

Type 2 diabetes mellitus (T2DM) is associated with depressive symptoms, and comorbid
depression in those with T2DM has been associated with adverse clinical profiles …

Background Metformin, a first-line antiglycemic drug, has been reported to have anti-
depressant effects in patients with type 2 diabetes; however, its exact role and underlying …

Patients with diabetes mellitus (DM) need psychological support throughout their life span
from the time of diagnosis. The psychological make-up of the patients with DM play a central …

Recent advanced immunological analyses have revealed that the diversity and plasticity of
macrophages lead to the identification of functional polarization states (classically activated …